However, in TNBC patients with low EHF expression, the re-induction or modulation of EHF expression by demethylating agents needs to be considered with caution because demethylating agents have broad transcriptional effects and EHF has a tumor promoting role in gastric and thyroid cancers. This evidence concerns the gene EHF and thyroid cancer.